SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (859)2/5/2002 11:32:45 AM
From: nigel bates  Read Replies (24) of 2243
 
guess it's time to add up the parts of the whole.

I think there's Amarin, Atrix, Bioject, Cytogen, Depomed, Draxis, Incara, Ligand, Emisphere, Integra, Iomed, Isis, Nanogen, Ribozyme and Targeted Genetics among the quoted. Please feel free to add to the list, as have only just started looking at Elan in any detail.

These 81%/19% joint ventures are kind of weird, and EIS, EPIL 1 and EPIL 11 add to the confusion...

nig
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext